Impact of continuation of antipsychotic medications and benzodiazepines after critical care discharge
Puntos clave
This research aims to evaluate the effects of continuing antipsychotic and benzodiazepine medications after ICU discharge.
Examined medication use among ICU survivors.
Analyzed prescribing practices of nurse practitioners.
Evaluated outcomes related to continued medication post-discharge.
Findings suggest reconsideration of antipsychotic and benzodiazepine prescriptions.
Indicates potential negative impacts on ICU survivors' recovery.
Resumen
Nurse practitioners should reevaluate the use of antipsychotics and/or benzodiazepines in the ICU and avoid discharging ICU survivors with a new prescription.